| Year |
Citation |
Score |
| 2010 |
Iarkov AV, Der TC, Joyce JN. Age-related differences in MK-801 induced behaviors in dopamine D3 receptor knock out mice. European Journal of Pharmacology. 627: 177-84. PMID 19909735 DOI: 10.1016/J.Ejphar.2009.11.012 |
0.475 |
|
| 2010 |
Yarkov AV, Der TC, Joyce JN. Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor. European Journal of Pharmacology. 627: 167-72. PMID 19900441 DOI: 10.1016/J.Ejphar.2009.10.068 |
0.52 |
|
| 2009 |
Mastroeni D, Grover A, Leonard B, Joyce JN, Coleman PD, Kozik B, Bellinger DL, Rogers J. Microglial responses to dopamine in a cell culture model of Parkinson's disease. Neurobiology of Aging. 30: 1805-17. PMID 18325635 DOI: 10.1016/J.Neurobiolaging.2008.01.001 |
0.518 |
|
| 2008 |
Bychkov ER, Gurevich VV, Joyce JN, Benovic JL, Gurevich EV. Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia Neurobiology of Aging. 29: 379-396. PMID 17125886 DOI: 10.1016/J.Neurobiolaging.2006.10.012 |
0.357 |
|
| 2007 |
Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? International Review of Neurobiology. 82: 235-46. PMID 17678964 DOI: 10.1016/S0074-7742(07)82012-5 |
0.303 |
|
| 2007 |
Joyce JN, Millan MJ. Dopamine D3 receptor agonists for protection and repair in Parkinson's disease. Current Opinion in Pharmacology. 7: 100-5. PMID 17174156 DOI: 10.1016/J.Coph.2006.11.004 |
0.51 |
|
| 2005 |
Joyce JN, Millan MJ. Dopamine D3 receptor antagonists as therapeutic agents. Drug Discovery Today. 10: 917-25. PMID 15993811 DOI: 10.1016/S1359-6446(05)03491-4 |
0.53 |
|
| 2005 |
Ueda S, Sakakibara S, Nakadate K, Noda T, Shinoda M, Joyce JN. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E. Neuroscience Letters. 380: 252-6. PMID 15862896 DOI: 10.1016/J.Neulet.2005.01.053 |
0.342 |
|
| 2004 |
Presgraves SP, Borwege S, Millan MJ, Joyce JN. Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells. Experimental Neurology. 190: 157-70. PMID 15473989 DOI: 10.1016/J.Expneurol.2004.06.021 |
0.749 |
|
| 2004 |
Joyce JN, Woolsey C, Ryoo H, Borwege S, Hagner D. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor. Bmc Biology. 2: 22. PMID 15473914 DOI: 10.1186/1741-7007-2-22 |
0.476 |
|
| 2004 |
Presgraves SP, Ahmed T, Borwege S, Joyce JN. Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotoxicity Research. 5: 579-98. PMID 15111235 DOI: 10.1007/Bf03033178 |
0.738 |
|
| 2004 |
Neisewander JL, Fuchs RA, Tran-Nguyen LT, Weber SM, Coffey GP, Joyce JN. Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1479-87. PMID 15100700 DOI: 10.1038/Sj.Npp.1300456 |
0.428 |
|
| 2004 |
Joyce JN, Der TC, Renish L, Osredkar T, Hagner D, Reploge M, Sakakibara S, Ueda S. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment. Experimental Neurology. 187: 178-89. PMID 15081599 DOI: 10.1016/J.Expneurol.2004.01.012 |
0.507 |
|
| 2004 |
Millan MJ, Di Cara B, Hill M, Jackson M, Joyce JN, Brotchie J, McGuire S, Crossman A, Smith L, Jenner P, Gobert A, Peglion JL, Brocco M. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole. The Journal of Pharmacology and Experimental Therapeutics. 309: 921-35. PMID 14978195 DOI: 10.1124/Jpet.103.062414 |
0.474 |
|
| 2004 |
Joyce JN, Renish L, Osredkar T, Walro JM, Kucera J, Dluzen DE. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations. Synapse (New York, N.Y.). 52: 11-9. PMID 14755628 DOI: 10.1002/Syn.10309 |
0.52 |
|
| 2003 |
Yarkov AV, Hanger D, Reploge M, Joyce JN. Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice. Pharmacology, Biochemistry, and Behavior. 76: 551-62. PMID 14643855 DOI: 10.1016/J.Pbb.2003.09.011 |
0.519 |
|
| 2003 |
Joyce JN, Presgraves S, Renish L, Borwege S, Osredkar T, Hagner D, Replogle M, PazSoldan M, Millan MJ. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole. Experimental Neurology. 184: 393-407. PMID 14637109 DOI: 10.1016/S0014-4886(03)00353-4 |
0.492 |
|
| 2002 |
Joyce JN, Ryoo HL, Beach TB, Caviness JN, Stacy M, Gurevich EV, Reiser M, Adler CH. Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: Role of D3 and not D2 receptors Brain Research. 955: 138-152. PMID 12419530 DOI: 10.1016/S0006-8993(02)03396-6 |
0.496 |
|
| 2001 |
Joyce JN. Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs Pharmacology and Therapeutics. 90: 231-259. PMID 11578658 DOI: 10.1016/S0163-7258(01)00139-5 |
0.482 |
|
| 2001 |
Gurevich EV, Robertson RT, Joyce JN. Thalamo-cortical afferents control transient expression of the dopamine D(3) receptor in the rat somatosensory cortex. Cerebral Cortex (New York, N.Y. : 1991). 11: 691-701. PMID 11459759 DOI: 10.1093/Cercor/11.8.691 |
0.452 |
|
| 2001 |
Joyce JN. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period. Synapse (New York, N.Y.). 40: 137-44. PMID 11252025 DOI: 10.1002/Syn.1035 |
0.488 |
|
| 2001 |
Joyce JN, Ryoo H, Gurevich EV, Adler C, Beach T. Ventral striatal D3 receptors and Parkinson's Disease Parkinsonism and Related Disorders. 7: 225-230. DOI: 10.1016/S1353-8020(00)00060-2 |
0.515 |
|
| 2000 |
Gurevich EV, Kordower JH, Joyce JN. Ontogeny of the dopamine D2 receptor mRNA expressing cells in the human hippocampal formation and temporal neocortex Journal of Chemical Neuroanatomy. 20: 307-325. PMID 11207428 DOI: 10.1016/S0891-0618(00)00108-3 |
0.427 |
|
| 2000 |
Joyce JN, Yoshimoto K, Ueda S. The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system Neuroreport. 11: 2173-2175. PMID 10923665 DOI: 10.1097/00001756-200007140-00022 |
0.57 |
|
| 2000 |
Gurevich EV, Joyce JN. Dopamine D3 receptor is selectively and transiently expressed in the developing whisker barrel cortex of the rat Journal of Comparative Neurology. 420: 35-51. PMID 10745218 DOI: 10.1002/(Sici)1096-9861(20000424)420:1<35::Aid-Cne3>3.0.Co;2-K |
0.443 |
|
| 1999 |
Joyce JN, Gurevich EV. D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics Annals of the New York Academy of Sciences. 877: 595-613. PMID 10415673 DOI: 10.1111/J.1749-6632.1999.Tb09291.X |
0.581 |
|
| 1999 |
Neal-Beliveau BS, Joyce JN. Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions Neurotoxicology and Teratology. 21: 129-140. PMID 10192273 DOI: 10.1016/S0892-0362(98)00044-0 |
0.818 |
|
| 1999 |
Gurevich EV, Himes JW, Joyce JN. Developmental regulation of expression of the D3 dopamine receptor in rat nucleus accumbens and Islands of Calleja Journal of Pharmacology and Experimental Therapeutics. 289: 587-598. PMID 10087054 |
0.424 |
|
| 1999 |
Gurevich EV, Joyce JN. Distribution of dopamine D3 receptor expressing neurons in the human forebrain comparison with D2 receptor expressing neurons Neuropsychopharmacology. 20: 60-80. PMID 9885786 DOI: 10.1016/S0893-133X(98)00066-9 |
0.496 |
|
| 1999 |
Joyce JN, Gurevich EV. Dopamine D3 receptors: From anatomy to neuropsychiatry Neuroscience News. 2: 11-21. |
0.48 |
|
| 1998 |
Thomas WS, Neal-Beliveau BS, Joyce JN. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum Developmental Brain Research. 111: 99-106. PMID 9804909 DOI: 10.1016/S0165-3806(98)00126-6 |
0.828 |
|
| 1998 |
Joyce JN, Murray AM, Hurtig HI, Gottlieb GL, Trojanowski JQ. Loss of dopamine D2 receptors in Alzheimer's disease with parkinsonism but not Parkinson's or Alzheimer's disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 19: 472-80. PMID 9803423 DOI: 10.1016/S0893-133X(98)00044-X |
0.43 |
|
| 1998 |
Ryoo HL, Pierrotti D, Joyce JN. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease Movement Disorders. 13: 788-797. PMID 9756147 DOI: 10.1002/Mds.870130506 |
0.551 |
|
| 1998 |
Neal-Beliveau BS, Joyce JN. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development Developmental Psychobiology. 32: 313-326. PMID 9589220 DOI: 10.1002/(Sici)1098-2302(199805)32:4<313::Aid-Dev6>3.0.Co;2-Q |
0.828 |
|
| 1998 |
Joyce JN, Myers AJ, Gurevich E. Dopamine D2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease. Brain Research. 784: 7-17. PMID 9518532 DOI: 10.1016/S0006-8993(97)01005-6 |
0.489 |
|
| 1998 |
Mufson EJ, MA SY, Jaffar S, Ciliax BJ, Joyce J, Cochran E, Mash DC, Kordower JH, Levey AI. AGE RELATED CHANGES IN DOPAMINE TRANSPORTER IMMUNOREACTIVITY WITHIN THE HUMAN SUBSTANTIA NIGRA Journal of Neuropathology and Experimental Neurology. 57: 510. DOI: 10.1097/00005072-199805000-00184 |
0.382 |
|
| 1998 |
Joyce J, Gurevich E, Himes J, Ryoo H. Segregation and co-expression of D2 and D3 receptors in the brain of schizophrenic patients: Postmortem studies European Neuropsychopharmacology. 8: S82-S83. DOI: 10.1016/S0924-977X(98)80049-7 |
0.42 |
|
| 1998 |
Rioux L, Nissanov J, Joyce JN. Increased number of [125I] BH-substance P receptors in schizophrenia Progress in Neuro-Psychopharmacology and Biological Psychiatry. 22: 1295-1299. DOI: 10.1016/S0278-5846(98)00084-0 |
0.377 |
|
| 1997 |
Gurevich EV, Kordower J, Joyce JN. Dopamine D2 receptor mRNA is expressed in maturing neurons of the human hippocampal and subicular fields Neuroreport. 8: 3605-3610. PMID 9427335 DOI: 10.1097/00001756-199711100-00037 |
0.368 |
|
| 1997 |
Joyce JN, Smutzer G, Whitty CJ, Myers A, Bannon MJ. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 885-97. PMID 9399211 DOI: 10.1002/Mds.870120609 |
0.349 |
|
| 1997 |
Joyce JN, Goldsmith SG, Gurevich EV. Limbic circuits and monoamine receptors: Dissecting the effects of antipsychotics from disease processes Journal of Psychiatric Research. 31: 197-217. PMID 9278186 DOI: 10.1016/S0022-3956(96)00043-X |
0.469 |
|
| 1997 |
Goldsmith SK, Shapiro RM, Joyce JN. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia: A postmortem study Archives of General Psychiatry. 54: 649-658. PMID 9236549 DOI: 10.1001/Archpsyc.1997.01830190077008 |
0.453 |
|
| 1997 |
Joyce JN, Meador-Woodruff JH. Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 16: 375-84. PMID 9165493 DOI: 10.1016/S0893-133X(96)00276-X |
0.49 |
|
| 1997 |
Rioux L, Frohna PA, Joyce JN, Schneider JS. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of Parkinsonian monkeys Movement Disorders. 12: 148-158. PMID 9087972 DOI: 10.1002/Mds.870120204 |
0.496 |
|
| 1997 |
Gurevich EV, Bordelon Y, Shapiro RM, Arnold SE, Gur RE, Joyce JN. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. Archives of General Psychiatry. 54: 225-32. PMID 9075463 DOI: 10.1001/Archpsyc.1997.01830150047009 |
0.513 |
|
| 1997 |
Frohna PA, Neal-Beliveau BS, Joyce JN. Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions Synapse. 25: 293-305. PMID 9068128 DOI: 10.1002/(Sici)1098-2396(199703)25:3<293::Aid-Syn9>3.0.Co;2-6 |
0.779 |
|
| 1997 |
Gurevich EV, Joyce JN. Dopamine D2 receptor mRNA expression in the hippocampal formation of schizophrenics Schizophrenia Research. 24: 86. DOI: 10.1016/S0920-9964(97)82233-5 |
0.52 |
|
| 1996 |
Joyce JN, Frohna PA, Neal-Beliveau BS. Functional and molecular differentiation of the dopamine system induced by neonatal denervation Neuroscience and Biobehavioral Reviews. 20: 453-486. PMID 8880735 DOI: 10.1016/0149-7634(95)00025-9 |
0.797 |
|
| 1996 |
Goldsmith SK, Joyce JN. Dopamine D2 receptors are organized in bands in normal human temporal cortex Neuroscience. 74: 435-451. PMID 8865195 DOI: 10.1016/0306-4522(96)00132-7 |
0.49 |
|
| 1996 |
Solbrig MV, Koob GF, Joyce JN, Lipkin WI. A neural substrate of hyperactivity in Borna disease: Changes in brain dopamine receptors Virology. 222: 332-338. PMID 8806517 DOI: 10.1006/Viro.1996.0430 |
0.502 |
|
| 1995 |
Frohna PA, Rothblat DS, Joyce JN, Schneider JS. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism Synapse. 19: 46-55. PMID 7709343 DOI: 10.1002/Syn.890190107 |
0.591 |
|
| 1995 |
Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Annals of Neurology. 37: 300-12. PMID 7695230 DOI: 10.1002/Ana.410370306 |
0.416 |
|
| 1995 |
Frohna PA, Neal-Beliveau BS, Joyce JN. Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs Neuroscience. 68: 505-518. PMID 7477961 DOI: 10.1016/0306-4522(95)00155-C |
0.815 |
|
| 1995 |
Joyce J, Gurevich E, Kung H, Kung M, Bordelon Y, Shapiro R, Arnold S, Gur R. Dopamine D3 receptors are elevated in schizophrenic brain and decreased by neuroleptic treatment Schizophrenia Research. 15: 61. DOI: 10.1016/0920-9964(95)95193-D |
0.514 |
|
| 1994 |
Murray AM, Ryoo HL, Gurevich E, Joyce JN. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proceedings of the National Academy of Sciences of the United States of America. 91: 11271-5. PMID 7972046 DOI: 10.1073/Pnas.91.23.11271 |
0.513 |
|
| 1994 |
UÅ‚as J, Weihmuller FB, Brunner LC, Joyce JN, Marshall JF, Cotman CW. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 6317-24. PMID 7965038 DOI: 10.1523/Jneurosci.14-11-06317.1994 |
0.357 |
|
| 1994 |
Goldsmith SK, Joyce JN. Dopamine D2 receptor expression in hippocampus and parahippocampal cortex of rat, cat, and human in relation to tyrosine hydroxylase‐immunoreactive fibers Hippocampus. 4: 354-373. PMID 7842057 DOI: 10.1002/Hipo.450040318 |
0.487 |
|
| 1994 |
Ryoo HL, Joyce JN. Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease Journal of Comparative Neurology. 348: 94-110. PMID 7814686 DOI: 10.1002/Cne.903480105 |
0.478 |
|
| 1994 |
Gurevich E, Kung M, Bordelon Y, Joyce J. Mesolimbic dopamine D3 receptors: elevation in schizophrenics Biological Psychiatry. 35: 716. DOI: 10.1016/0006-3223(94)91021-9 |
0.563 |
|
| 1994 |
Frohna P, Joyce J. The developmental plasticity of the dopamine systems in the rodent basal ganglia Biological Psychiatry. 35: 688. DOI: 10.1016/0006-3223(94)90920-2 |
0.319 |
|
| 1993 |
Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 8: 315-36. PMID 8512620 DOI: 10.1038/Npp.1993.32 |
0.35 |
|
| 1993 |
Joyce JN. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinson's disease cases Brain Research. 600: 156-160. PMID 8422582 DOI: 10.1016/0006-8993(93)90414-I |
0.542 |
|
| 1993 |
Neal-Beliveau BS, Joyce JN, Lucki I. Serotonergic involvement in haloperidol-induced catalepsy. The Journal of Pharmacology and Experimental Therapeutics. 265: 207-17. PMID 8386235 |
0.778 |
|
| 1993 |
Joyce JN, Kaeger C, Ryoo H, Goldsmith S. Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease Neuroscience Letters. 154: 171-174. PMID 8361636 DOI: 10.1016/0304-3940(93)90199-U |
0.474 |
|
| 1993 |
Neal-Beliveau BS, Joyce JN. D1 and D2 dopamine receptors do not up-regulate in response to neonatal intrastriatal 6-hydroxydopamine lesions Neuroscience Letters. 160: 77-80. PMID 8247338 DOI: 10.1016/0304-3940(93)90917-A |
0.827 |
|
| 1993 |
Frohna PA, Neal-Beliveau BS, Joyce JN. Neonatal 6-OHDA lesions upregulate adult expression of tyrosine hydroxylase mRNA Neuroreport. 4: 1095-1098. PMID 8106005 |
0.771 |
|
| 1993 |
Joyce JN. The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine Psychopharmacology. 112. PMID 7831438 DOI: 10.1007/Bf02245004 |
0.361 |
|
| 1993 |
Joyce J, Murray A, Ryoo H, Goldsmith S, Kirkland K. Expression of D2 and D3 receptors in temporal lobe of normals, schizophrenics and patients with dementia Schizophrenia Research. 9: 221-222. DOI: 10.1016/0920-9964(93)90481-W |
0.412 |
|
| 1992 |
Murray AM, Ryoo H, Joyce JN. Visualization of dopamine D3-like receptors in human brain with [125I]epidepride. European Journal of Pharmacology. 227: 443-5. PMID 1359976 DOI: 10.1016/0922-4106(92)90164-Q |
0.519 |
|
| 1992 |
Neal BS, Joyce JN. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors Synapse. 11: 35-46. PMID 1351321 DOI: 10.1002/Syn.890110106 |
0.583 |
|
| 1992 |
Joyce JN, Goldsmith S, Murray A. Organization of dopamine receptors in human brain: Distinctions from nonhuman primate International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. 19: 114. DOI: 10.1016/0883-2897(92)90199-9 |
0.422 |
|
| 1991 |
Joyce JN. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment Experimental Neurology. 113: 277-290. PMID 1833220 DOI: 10.1016/0014-4886(91)90017-7 |
0.607 |
|
| 1991 |
Joyce JN. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system Experimental Neurology. 113: 261-276. PMID 1833219 DOI: 10.1016/0014-4886(91)90016-6 |
0.573 |
|
| 1991 |
Rao PA, Molinoff PB, Joyce JN. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Research. Developmental Brain Research. 60: 161-77. PMID 1832594 DOI: 10.1016/0165-3806(91)90045-K |
0.53 |
|
| 1991 |
Neal BS, Joyce JN. Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development Developmental Brain Research. 60: 105-113. PMID 1832593 DOI: 10.1016/0165-3806(91)90038-K |
0.591 |
|
| 1991 |
Joyce JN, Hensler JG, Tejani-Butt SM. Neurochemical Lesioning Techniques for Assessing Regulation of Monoamine Receptors Methods in Neurosciences. 7: 216-240. DOI: 10.1016/B978-0-12-185263-4.50021-2 |
0.39 |
|
| 1990 |
Lowenstein PR, Joyce JN, Coyle JT, Marshall JF. Striosomal organization of cholinergic and dopaminergic uptake sites and cholinergic M1 receptors in the adult human striatum: a quantitative receptor autoradiographic study. Brain Research. 510: 122-6. PMID 2322836 DOI: 10.1016/0006-8993(90)90736-U |
0.411 |
|
| 1990 |
Joyce JN, Hurtig H. Differential regulation of striatal dopamine D1 and D2 receptor systems in Parkinson's disease and effects of adrenal medullary transplant Progress in Brain Research. 82: 699-706. PMID 2290973 DOI: 10.1016/S0079-6123(08)62662-X |
0.513 |
|
| 1989 |
Joyce JN, Gibbs RB, Cotman CW, Marshall JF. Regulation of muscarinic receptors in hippocampus following cholinergic denervation and reinnervation by septal and striatal transplants. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 2776-91. PMID 2769366 DOI: 10.1523/Jneurosci.09-08-02776.1989 |
0.366 |
|
| 1989 |
Hurtig H, Joyce J, Sladek JR, Trojanowski JQ. Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. Annals of Neurology. 25: 607-14. PMID 2742361 DOI: 10.1002/Ana.410250613 |
0.42 |
|
| 1989 |
Marshall JF, Navarrete R, Joyce JN. Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis. Brain Research. 493: 247-57. PMID 2527583 DOI: 10.1016/0006-8993(89)91160-8 |
0.524 |
|
| 1989 |
Joyce JN, Lawrence D, Lexow N, Neal B, Winokur A. Alterations in dopaminergic, serotonergic and B-adrenergic systems within limbic associated regions of schizophrenic striatum Biological Psychiatry. 25: A100-A101. DOI: 10.1016/0006-3223(89)91689-2 |
0.339 |
|
| 1989 |
Lexow N, Phillips J, Joyce JN, Winokur A. Schizophrenic postmortem studies: Alterations in the distribution of trh receptors in the temporal lobe Biological Psychiatry. 25: A61. DOI: 10.1016/0006-3223(89)91610-7 |
0.378 |
|
| 1988 |
Marshall JF, Joyce JN. Basal ganglia dopamine receptor autoradiography and age-related movement disorders. Annals of the New York Academy of Sciences. 515: 215-25. PMID 3364885 DOI: 10.1111/J.1749-6632.1988.Tb32988.X |
0.417 |
|
| 1988 |
Joyce JN, Gibbs RB, Cotman CW, Marshall JF. Regulation of acetylcholine muscarinic receptors by embryonic septal grafts showing cholinergic innervation of host hippocampus. Progress in Brain Research. 78: 109-16. PMID 3247416 DOI: 10.1016/S0079-6123(08)60273-3 |
0.366 |
|
| 1988 |
Joyce JN, Lexow N, Bird E, Winokur A. Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia Synapse. 2: 546-557. PMID 2973147 DOI: 10.1002/Syn.890020511 |
0.524 |
|
| 1987 |
Rhodes KJ, Joyce JN, Sapp DW, Marshall JF. [3H]hemicholinium-3 binding in rabbit striatum: correspondence with patchy acetylcholinesterase staining and a method for quantifying striatal compartments. Brain Research. 412: 400-4. PMID 3607475 DOI: 10.1016/0006-8993(87)91151-6 |
0.309 |
|
| 1987 |
Joyce JN, Marshall JF. Quantitative autoradiography of dopamine D2 sites in rat caudate-putamen: localization to intrinsic neurons and not to neocortical afferents. Neuroscience. 20: 773-95. PMID 2955247 DOI: 10.1016/0306-4522(87)90240-5 |
0.462 |
|
| 1986 |
Joyce JN, Sapp DW, Marshall JF. Human striatal dopamine receptors are organized in compartments. Proceedings of the National Academy of Sciences of the United States of America. 83: 8002-6. PMID 2945207 DOI: 10.1073/Pnas.83.20.8002 |
0.52 |
|
| 1986 |
Joyce JN, Marshall JF, Bankiewicz KS, Kopin IJ, Jacobowitz DM. Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density. Brain Research. 382: 360-4. PMID 2944565 DOI: 10.1016/0006-8993(86)91345-4 |
0.505 |
|
| 1986 |
Joyce JN, Loeschen SK, Sapp DW, Marshall JF. Age-related regional loss of caudate-putamen dopamine receptors revealed by quantitative autoradiography. Brain Research. 378: 158-63. PMID 2943360 DOI: 10.1016/0006-8993(86)90298-2 |
0.417 |
|
| 1986 |
Van Hartesveldt C, Joyce JN. Effects of estrogen on the basal ganglia. Neuroscience and Biobehavioral Reviews. 10: 1-14. PMID 2871534 DOI: 10.1016/0149-7634(86)90029-1 |
0.688 |
|
| 1985 |
Joyce JN, Loeschen SK, Marshall JF. Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation. Brain Research. 338: 209-18. PMID 3161583 DOI: 10.1016/0006-8993(85)90149-0 |
0.539 |
|
| 1985 |
Joyce JN, Marshall JF. Striatal topography of D-2 receptors correlates with indexes of cholinergic neuron localization. Neuroscience Letters. 53: 127-31. PMID 3157889 DOI: 10.1016/0304-3940(85)90108-9 |
0.513 |
|
| 1984 |
Joyce JN, van Hartesveldt C. Rotation and postural deviation elicited by microinjections of dopamine into medial and lateral regions of dorsal striatum. Pharmacology, Biochemistry, and Behavior. 21: 979-81. PMID 6522422 DOI: 10.1016/S0091-3057(84)80084-2 |
0.708 |
|
| 1984 |
Joyce JN, Montero E, Van Hartesveldt C. Dopamine-mediated behaviors: characteristics of modulation by estrogen. Pharmacology, Biochemistry, and Behavior. 21: 791-800. PMID 6514769 DOI: 10.1016/S0091-3057(84)80021-0 |
0.717 |
|
| 1984 |
Joyce JN, Van Hartesveldt C. Estradiol application to one striatum produces postural deviation to systemic apomorphine. Pharmacology, Biochemistry, and Behavior. 20: 575-81. PMID 6374687 DOI: 10.1016/0091-3057(84)90307-1 |
0.685 |
|
| 1984 |
Joyce JN, Van Hartesveldt C. Behaviors induced by intrastriatal dopamine vary independently across the estrous cycle. Pharmacology, Biochemistry, and Behavior. 20: 551-7. PMID 6374686 DOI: 10.1016/0091-3057(84)90304-6 |
0.692 |
|
| 1983 |
Joyce JN, Davis RE, Van Hartesveldt C. Systemic apomorphine reverses intrastriatal dopamine-induced contralateral deviation. European Journal of Pharmacology. 87: 283-9. PMID 6840191 DOI: 10.1016/0014-2999(83)90339-4 |
0.724 |
|
| 1983 |
Joyce JN. Multiple dopamine receptors and behavior Neuroscience and Biobehavioral Reviews. 7: 227-256. PMID 6136014 DOI: 10.1016/0149-7634(83)90017-9 |
0.498 |
|
| 1982 |
Joyce JN, Smith RL, van Hartesveldt C. Estradiol suppresses then enhances intracaudate dopamine-induced contralateral deviation. European Journal of Pharmacology. 81: 117-22. PMID 7117364 DOI: 10.1016/0014-2999(82)90608-2 |
0.697 |
|
| 1981 |
Joyce JN, Davis RE, Van Hartesveldt C. Behavioral effects of unilateral dopamine injection into dorsal or ventral striatum. European Journal of Pharmacology. 72: 1-10. PMID 7196334 DOI: 10.1016/0014-2999(81)90290-9 |
0.728 |
|
| Show low-probability matches. |